Albert D. Mason Inc’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.93M | Buy |
25,727
+140
| +0.5% | +$21.5K | 2.54% | 4 |
|
|
2025
Q4 | $3.53M | Buy |
25,587
+88
| +0.3% | +$11.5K | 2.32% | 3 |
|
|
2025
Q3 | $3.27M | Buy |
25,499
+1,135
| +5% | +$138K | 2.13% | 4 |
|
|
2025
Q2 | $2.95M | Sell |
24,364
-1,664
| -6% | -$188K | 2.13% | 4 |
|
|
2025
Q1 | $2.9M | Buy |
26,028
+12,774
| +96% | +$1.36M | 1.97% | 4 |
|
|
2024
Q4 | $1.29M | Sell |
13,254
-223
| -2% | -$23.8K | 0.86% | 47 |
|
|
2024
Q3 | $1.55M | Sell |
13,477
-74
| -0.5% | -$8.4K | 0.99% | 38 |
|
|
2024
Q2 | $1.44M | Buy |
13,551
+63
| +0.5% | +$6.32K | 0.98% | 40 |
|
|
2024
Q1 | $1.3M | Buy |
13,488
+17
| +0.1% | +$1.74K | 0.81% | 53 |
|
|
2023
Q4 | $1.36M | Sell |
13,471
-30
| -0.2% | -$2.9K | 0.9% | 40 |
|
|
2023
Q3 | $1.38M | Sell |
13,501
-1,480
| -10% | -$150K | 1% | 30 |
|
|
2023
Q2 | $1.51M | Sell |
14,981
-437
| -3% | -$43.7K | 1.04% | 28 |
|
|
2023
Q1 | $1.42M | Sell |
15,418
-64
| -0.4% | -$5.59K | 0.98% | 34 |
|
|
2022
Q4 | $1.41M | Sell |
15,482
-23
| -0.1% | -$1.94K | 1% | 34 |
|
|
2022
Q3 | $1.18M | Buy |
15,505
+90
| +0.6% | +$7.46K | 0.94% | 42 |
|
|
2022
Q2 | $1.3M | Buy |
15,415
+17
| +0.1% | +$1.49K | 0.97% | 31 |
|
|
2022
Q1 | $1.35M | Sell |
15,398
-294
| -2% | -$25.5K | 0.87% | 42 |
|
|
2021
Q4 | $1.37M | Buy |
15,692
+2,494
| +19% | +$207K | 0.82% | 46 |
|
|
2021
Q3 | $1.08M | Buy |
13,198
+38
| +0.3% | +$3.42K | 0.7% | 66 |
|
|
2021
Q2 | $1.2M | Sell |
13,160
-430
| -3% | -$38.3K | 0.74% | 61 |
|
|
2021
Q1 | $1.16M | Sell |
13,590
-135
| -1% | -$12.1K | 0.76% | 58 |
|
|
2020
Q4 | $1.3M | Buy |
13,725
+146
| +1% | +$12.8K | 0.9% | 47 |
|
|
2020
Q3 | $1.18M | Buy |
13,579
+225
| +2% | +$19.5K | 0.97% | 40 |
|
|
2020
Q2 | $1.17M | Sell |
13,354
-70
| -0.5% | -$6.04K | 0.98% | 41 |
|
|
2020
Q1 | $1.11M | Buy |
13,424
+45
| +0.3% | +$4.01K | 1.11% | 34 |
|
|
2019
Q4 | $1.27M | Buy |
13,379
+225
| +2% | +$20.2K | 0.9% | 46 |
|
|
2019
Q3 | $1.14M | Buy |
13,154
+45
| +0.3% | +$4.04K | 0.86% | 51 |
|
|
2019
Q2 | $1.2M | Sell |
13,109
-1,599
| -11% | -$135K | 0.9% | 46 |
|
|
2019
Q1 | $1.27M | Buy |
14,708
+156
| +1% | +$12.5K | 0.93% | 45 |
|
|
2018
Q4 | $1.12M | Sell |
14,552
-83
| -0.6% | -$6.46K | 0.91% | 43 |
|
|
2018
Q3 | $1.13M | Buy |
14,635
+2,807
| +24% | +$208K | 0.77% | 59 |
|
|
2018
Q2 | $801K | Buy |
11,828
+2,678
| +29% | +$185K | 0.58% | 80 |
|
|
2018
Q1 | $663K | Sell |
9,150
-39
| -0.4% | -$2.97K | 0.5% | 83 |
|
|
2017
Q4 | $691K | Buy |
9,189
+28
| +0.3% | +$2.11K | 0.52% | 87 |
|
|
2017
Q3 | $705K | Sell |
9,161
-7,254
| -44% | -$548K | 0.57% | 81 |
|
|
2017
Q2 | $1.23M | Hold |
16,415
| – | – | 1.03% | 38 |
|
|
2017
Q1 | $1.09M | Sell |
16,415
-11
| -0.1% | -$733 | 0.93% | 42 |
|
|
2016
Q4 | $1.07M | Sell |
16,426
-23,792
| -59% | -$1.54M | 0.94% | 44 |
|
|
2016
Q3 | $2.85M | Buy |
40,218
+18,904
| +89% | +$1.38M | 0.92% | 44 |
|
|
2016
Q2 | $1.58M | Buy |
21,314
+71
| +0.3% | +$4.91K | 0.92% | 42 |
|
|
2016
Q1 | $1.38M | Hold |
21,243
| – | – | 0.84% | 46 |
|
|
2015
Q4 | $1.64M | Sell |
21,243
-538
| -2% | -$42.7K | 1.07% | 37 |
|
|
2015
Q3 | $1.79M | Buy |
21,781
+6,101
| +39% | +$543K | 1.11% | 38 |
|
|
2015
Q2 | $1.38M | Sell |
15,680
-55,173
| -78% | -$5.06M | 0.75% | 53 |
|
|
2015
Q1 | $6.26M | Sell |
70,853
-13,266
| -16% | -$1.18M | 1.3% | 22 |
|
|
2014
Q4 | $6.98M | Buy |
84,119
+246
| +0.3% | +$20.4K | 1.39% | 22 |
|
|
2014
Q3 | $7.07M | Buy |
83,873
+547
| +0.7% | +$44.3K | 1.39% | 23 |
|
|
2014
Q2 | $6.76M | Sell |
83,326
-23,246
| -22% | -$1.83M | 1.23% | 30 |
|
|
2014
Q1 | $8.12M | Sell |
106,572
-13,058
| -11% | -$952K | 1.59% | 17 |
|
|
2013
Q4 | $8.62M | Sell |
119,630
-14,156
| -11% | -$984K | 1.7% | 12 |
|
|
2013
Q3 | $9.2M | Sell |
133,786
-865
| -0.6% | -$57.2K | 1.93% | 6 |
|
|
2013
Q2 | $8.53M | Buy |
+134,651
| New | +$8.76M | 1.89% | 10 |
|
Other funds holding NVS
Albert D. Mason Inc's NVS Position: Q1 2026 in Review
Albert D. Mason Inc increased its Novartis (NVS) stake by 0.55% in Q1 2026, buying an estimated $21.5K and bringing the position to 25,727 shares worth $3.93M. The position accounts for 2.54% of the portfolio, ranked #4.
Albert D. Mason Inc first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.2M in Q3 2013. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Albert D. Mason Inc held 25,727 shares of Novartis worth $3.93M as of Q1 2026.
- Albert D. Mason Inc bought 140 Novartis shares in Q1 2026, an estimated $21.5K.
- Novartis made up 2.54% of Albert D. Mason Inc's portfolio in Q1 2026, its #4 holding.
- Albert D. Mason Inc first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Albert D. Mason Inc's Novartis position peaked at $9.2M in Q3 2013.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Albert D. Mason Inc's 13F filing for Q1 2026, filed 15 Apr 2026.